PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.\', \'Division of Veterinary Services, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.\', \'Division of Veterinary Resources, Diagnostic and Research Services Branch, National Institutes of Health, Rockville Pike, MD, USA.\', \'Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA tony.wang@fda.hhs.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • e20200088610.26508/lsa.202000886
?:doi
?:hasPublicationType
?:journal
  • Life science alliance
is ?:pmid of
?:pmid
?:pmid
  • 33574037
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all